Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine for preventing and treating stiff lump caused by phlebitis and injection

A technology for phlebitis and phlebitis, applied in the direction of drug combination, cardiovascular system diseases, active ingredients of heterocyclic compounds, etc., can solve problems such as phlebitis, achieve long-lasting drug effect, good effect, and prevent phlebitis

Inactive Publication Date: 2005-03-16
李德明 +2
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

During the injection process, it is easy to cause hard swelling and other situations

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] Take 2% by weight of anisodamine hydrobromide (654-2), add appropriate amount of water to stir and dissolve for later use; take 0.8% by weight of Carbomer-940 and add 20% by weight of glycerin to make a paste, then add lauryl nitrogen 2% by weight of ketone, 0.6% by weight of 5% paraben alcohol solution, stir evenly, then add the above-mentioned standby anisodamine hydrobromide solution, and adjust 3% by weight of triethanolamine into a transparent state, add water to 100% parts by weight.

Embodiment 2

[0033] The consumption (by weight) of each component is:

[0034] Anisodamine Hydrobromide 3%

[0035] Carbomer-940 1%

[0036] Glycerin 29%

[0037] Laurocaprine 1%

[0038] 5% paraben alcohol solution 0.4%

[0039] Triethanolamine 5%

[0040] The balance is water.

[0041] All the other are with embodiment 1.

Embodiment 3

[0043] The consumption (by weight) of each component is:

[0044] Anisodamine Hydrobromide 0.2%

[0045] Carbomer-940 0.6%

[0046] Glycerin 25%

[0047] Laurozone 0.5%

[0048] 5% paraben alcohol solution 0.3%

[0049] Triethanolamine 0.8%

[0050] The balance is water. All the other are with embodiment 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicament for treating hard turgescence caused by phlebitis and injection, wherein the medicament comprises Anisodamine Hydrobromide, carbomer-940, glycerin, Laurocapram and water. The medicament is in gel form and can be coated directly onto human skin.

Description

Technical field: [0001] The present invention relates to a medicine. Background technique: [0002] To the treatment of phlebitis in the prior art, there is still no obvious curative effect, easy-to-use medicine. In the injection process, it is easy to cause hard swelling and other situations. Invention content: [0003] The object of the present invention is to provide a medicine that is directly applied to the skin, is convenient to use, has a long-lasting medicinal effect, and can effectively prevent and treat phlebitis and hard swelling caused by injection. [0004] Technical solution of the present invention is: [0005] A medicine for preventing and treating phlebitis and hard swelling caused by injection is characterized in that it contains the following components by weight: [0006] Anisodamine hydrobromide 0.1~3% [0007] Carbomer-940 0.6~1% [0008] Glycerin 20~30% [0009] Laurozone 0.5~2% [0010] Water 68-78%. [0011] The medicine for preventing and ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/46A61P9/14
Inventor 李德明王华范义凤
Owner 李德明
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products